Next report date
Report period
Q1 2024
EPS estimate
−0.54USD
Revenue estimate
—
−71.58 MUSD
25.32 M
Om Enliven Therapeutics, Inc.
Sektor
Bransch
VD
Samuel S. Kintz
Webbplats
Huvudkvarter
Boulder
Employees (FY)
46
Grundat
2019
FIGI
BBG00CP3BDD4
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
